Get notified when VMD files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Director Sabrina Heltz Received 20.2% Opposition (new) — Elevated vote withholding compared to other directors may signal shareholder concerns about this board member's qualifications or performance.
NASDAQ: VMD VIEMED HEALTHCARE, INC. 8-K

Viemed shareholders approve equity plan expansion to 7.7M shares, elect all directors

Filed June 4, 2026 · Period ending June 4, 2026 · ~1 min read

Key Changes

  • medium

    Shareholders approved expansion of 2024 Long Term Incentive Plan to 7,696,717 total shares (including up to 1M incentive stock options) with 88.9% support, providing additional capacity for employee equity compensation.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • medium

    Director Sabrina Heltz elected with 79.8% support versus 93.3%–97.7% for other six directors; 20.2% of votes withheld represents elevated opposition compared to board peers.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
  • medium

    Say-on-pay vote passed with 93.2% support (6.2% against), indicating strong shareholder endorsement of executive compensation practices.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.

Partner

Trade VMD commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify